Business Context and Reporting Period
Company: Assembly Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2017
Reporting Period: Single event date (September 26, 2017)
Context: The filing serves to disclose a corporate presentation intended for use in investor meetings. The Company is an emerging growth company.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a presentation rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The primary event is the furnishing of a corporate presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
Management Commentary: The Company intends to use the attached corporate presentation in meetings with investors and others beginning September 26, 2017. The presentation is also available on the Company's investor website.
Regulatory Status: The information in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. It is not subject to the liabilities of that section nor incorporated by reference in other filings, except as expressly set forth by specific reference.
Risks and Contingencies: No specific risks or contingencies are disclosed in this text.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation dated September 26, 2017) for specific financial data and strategic outlook, as this 8-K only references the document.
- Verify the content on the Company's investor website at http://investor.assemblybio.com/events.cfm.
- Note that the presentation is not legally "filed" and carries different liability standards than a formal 10-K or 10-Q.